{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:40:11Z","timestamp":1795218011766,"version":"4.10.3"},"reference-count":49,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The demographics, immunologic parameters, medical complications, and mortality statistics from 473 subjects with common variable immune deficiency followed over 4 decades in New York were analyzed. Median immunoglobulin levels were IgG, 246 mg\/dL; IgA, 8 mg\/dL; and IgM, 21 mg\/dL; 22.6% had an IgG less than 100 mg\/dL. Males were diagnosed earlier (median age, 30 years) than females (median age, 33.5 years; P = .004). Ninety-four percent of patients had a history of infections; 68% also had noninfectious complications: hematologic or organ-specific autoimmunity, 28.6%; chronic lung disease, 28.5%; bronchiectasis, 11.2%; gastrointestinal inflammatory disease, 15.4%; malabsorption, 5.9%; granulomatous disease, 9.7%; liver diseases and hepatitis, 9.1%; lymphoma, 8.2%; or other cancers, 7.0%. Females had higher baseline serum IgM (P = .009) and were more likely to develop lymphoma (P = .04); 19.6% of patients died, a significantly shorter survival than age- and sex-matched population controls (P &lt; .0001). Reduced survival was associated with age at diagnosis, lower baseline IgG, higher IgM, and fewer peripheral B cells. The risk of death was 11 times higher for patients with noninfectious complications (hazard ratio = 10.95; P &lt; .0001). Mortality was associated with lymphoma, any form of hepatitis, functional or structural lung impairment, and gastrointestinal disease with or without malabsorption, but not with bronchiectasis, autoimmunity, other cancers, granulomatous disease, or previous splenectomy.<\/jats:p>","DOI":"10.1182\/blood-2011-09-377945","type":"journal-article","created":{"date-parts":[[2011,12,17]],"date-time":"2011-12-17T01:42:28Z","timestamp":1324086148000},"page":"1650-1657","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":763,"title":["Morbidity and mortality in common variable immune deficiency over 4 decades"],"prefix":"10.1182","volume":"119","author":[{"given":"Elena S.","family":"Resnick","sequence":"first","affiliation":[{"name":"Immunology Institute and"},{"name":"Departments of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Moshier","sequence":"additional","affiliation":[{"name":"Preventative Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Godbold","sequence":"additional","affiliation":[{"name":"Preventative Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[{"name":"Immunology Institute and"},{"name":"Departments of Medicine,"},{"name":"Pediatrics, Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111808024085500_B1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"issue":"5","key":"2019111808024085500_B2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11882-001-0027-1","article-title":"Common variable immunodeficiency.","volume":"1","author":"Cunningham-Rundles","year":"2001","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"2019111808024085500_B3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions.","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111808024085500_B4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update.","volume":"124","author":"Notarangelo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2019111808024085500_B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency.","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111808024085500_B6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients.","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"issue":"2","key":"2019111808024085500_B7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes.","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"issue":"3-4","key":"2019111808024085500_B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10428199909145724","article-title":"Plasma cell generation from B-lymphocytes via CD27\/CD70 interaction.","volume":"35","author":"Agematsu","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2019111808024085500_B9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111808024085500_B10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-11-321695","article-title":"T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency.","volume":"118","author":"Ochtrop","year":"2011","journal-title":"Blood"},{"key":"2019111808024085500_B11","first-page":"200","article-title":"Agammaglobulinemia.","volume":"66","author":"Janeway","year":"1953","journal-title":"Trans Assoc Am Physicians"},{"issue":"3","key":"2019111808024085500_B12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol"},{"issue":"18","key":"2019111808024085500_B13","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene.","volume":"354","author":"van Zelm","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111808024085500_B14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.gene.6364431","article-title":"Novel mutations in a Japanese patient with CD19 deficiency.","volume":"8","author":"Kanegane","year":"2007","journal-title":"Genes Immun"},{"issue":"33","key":"2019111808024085500_B15","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808024085500_B16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell-independent antibody responses.","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111808024085500_B17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.","volume":"120","author":"van Zelm","year":"2010","journal-title":"J Clin Invest"},{"issue":"8","key":"2019111808024085500_B18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"issue":"8","key":"2019111808024085500_B19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency.","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"issue":"4","key":"2019111808024085500_B20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.","volume":"39","author":"Pan-Hammarstr\u00f6m","year":"2007","journal-title":"Nat Genet"},{"issue":"5","key":"2019111808024085500_B21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"2019111808024085500_B22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"2019111808024085500_B23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts.","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2019111808024085500_B24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency.","volume":"127","author":"Orange","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2019111808024085500_B25","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2019111808024085500_B26","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.","volume":"125","author":"Lucas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2019111808024085500_B27","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"issue":"2","key":"2019111808024085500_B28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1011012023616","article-title":"Diagnostic findings in 95 Finnish patients with common variable immunodeficiency.","volume":"21","author":"Kainulainen","year":"2001","journal-title":"J Clin Immunol"},{"issue":"3","key":"2019111808024085500_B29","first-page":"140","article-title":"Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution.","volume":"60","author":"Van der Hilst","year":"2002","journal-title":"Neth J Med"},{"issue":"2","key":"2019111808024085500_B30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.","volume":"114","author":"Bates","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2019111808024085500_B31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"issue":"5","key":"2019111808024085500_B32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"issue":"3","key":"2019111808024085500_B33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences.","volume":"128","author":"S\u00e1nchez-Ram\u00f3n","year":"2008","journal-title":"Clin Immunol"},{"key":"2019111808024085500_B34","article-title":"Vital statistics of the United States, 1994, preprint of vol II, mortality, part A sec 6 life tables.","author":"National Center for Health Statistics","year":"1998"},{"key":"2019111808024085500_B35","volume-title":"SAS System for Windows Version 9.2 computer program","author":"SAS Institute"},{"issue":"2","key":"2019111808024085500_B36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajh.2830370202","article-title":"Non-Hodgkin lymphoma in common variable immunodeficiency.","volume":"37","author":"Cunningham-Rundles","year":"1991","journal-title":"Am J Hematol"},{"issue":"9","key":"2019111808024085500_B37","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/leu.2011.117","article-title":"Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.","volume":"25","author":"Lanasa","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"2019111808024085500_B38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency.","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"2019111808024085500_B39","first-page":"115","article-title":"Hypogammaglobulinaemia in the United Kingdom. XII. Statistical analyses: prevalence, mortality and effects of treatment.","volume":"310","author":"Healy","year":"1971","journal-title":"Spec Rep Ser Med Res Counc"},{"issue":"6","key":"2019111808024085500_B40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency.","volume":"109","author":"Busse","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2019111808024085500_B41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study.","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"8423","key":"2019111808024085500_B42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(85)91037-2","article-title":"Prospective study of cancer in patients with hypogammaglobulinaemia.","volume":"1","author":"Kinlen","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"2019111808024085500_B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","article-title":"Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme.","volume":"165","author":"Dhalla","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2019111808024085500_B44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00915550","article-title":"Incidence of cancer in 98 patients with common varied immunodeficiency.","volume":"7","author":"Cunningham-Rundles","year":"1987","journal-title":"J Clin Immunol"},{"issue":"5","key":"2019111808024085500_B45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.","volume":"23","author":"Piqueras","year":"2003","journal-title":"J Clin Immunol"},{"issue":"2","key":"2019111808024085500_B46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","article-title":"A new CD21low B cell population in the peripheral blood of patients with SLE.","volume":"113","author":"Wehr","year":"2004","journal-title":"Clin Immunol"},{"issue":"1","key":"2019111808024085500_B47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","article-title":"Immune competence and switched memory B cells in common variable immunodeficiency.","volume":"116","author":"Ko","year":"2005","journal-title":"Clin Immunol"},{"issue":"3","key":"2019111808024085500_B48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clim.2006.05.003","article-title":"Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency.","volume":"120","author":"Alachkar","year":"2006","journal-title":"Clin Immunol"},{"issue":"24","key":"2019111808024085500_B49","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21-negative human naive B cells mostly contain autoreactive unresponsive clones.","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1650\/1356365\/zh800712001650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/7\/1650\/1356365\/zh800712001650.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:19:44Z","timestamp":1574065184000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/7\/1650\/30111\/Morbidity-and-mortality-in-common-variable-immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-09-377945","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}